Text & Content Analysis
This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
Explore by Category
Corpus KPIs
Entity
protalix
Articles
1
From
2026-03-11 10:50:00+00
To
2026-03-11 10:50:00+00
Range
2026-03-10 13:57:07.545815+00 →
2026-03-11 13:57:07.545815+00
Who’s being talked about
Top Entities
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| american | NORP | 1 | 📊 🔍 🧲 |
| announce fiscal year 2025 | ORG | 1 | 📊 🔍 🧲 |
| brazil | GPE | 1 | 📊 🔍 🧲 |
| chiesi farmaceutici spa | ORG | 1 | 📊 🔍 🧲 |
| company | ORG | 1 | 📊 🔍 🧲 |
| elfabrio | PERSON | 1 | 📊 🔍 🧲 |
| fda | ORG | 1 | 📊 🔍 🧲 |
| food and drug administration | ORG | 1 | 📊 🔍 🧲 |
| gaucher | PERSON | 1 | 📊 🔍 🧲 |
| israel | GPE | 1 | 📊 🔍 🧲 |
| lifesci advisors | PERSON | 1 | 📊 🔍 🧲 |
| mike moyer | PERSON | 1 | 📊 🔍 🧲 |
| nyse | ORG | 1 | 📊 🔍 🧲 |
| pfizer inc | ORG | 1 | 📊 🔍 🧲 |
| protalix | FAC | 1 | 📊 🔍 🧲 |
| protalix biotherapeutics | ORG | 1 | 📊 🔍 🧲 |
| protalix biotherapeutics inc | ORG | 1 | 📊 🔍 🧲 |
| prx115 | PERSON | 1 | 📊 🔍 🧲 |
| prx119 | ORG | 1 | 📊 🔍 🧲 |
| share to x company | PRODUCT | 1 | 📊 🔍 🧲 |
| share to x share | PRODUCT | 1 | 📊 🔍 🧲 |
| source protalix biotherapeutics | PERSON | 1 | 📊 🔍 🧲 |
| u.s. | GPE | 1 | 📊 🔍 🧲 |
| webcast details | PERSON | 1 | 📊 🔍 🧲 |
| webcast link | PERSON | 1 | 📊 🔍 🧲 |
Articles included
Top entities
Top sources
Top narrative frames
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-03-11 10:50:00+00 | Business |
|
Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026 | Analyze | Protalix BioTherapeutics, Inc. | 😐 neutral | 0.1358 |